AWARD AMOUNT
$100,000 per project per year for up to two years
POSTED DATE
Monday, December 14, 2020
DEADLINE FOR APPLICATION
Friday, February 26, 2021
ANTICIPATED AWARD DATE
Friday, April 30, 2021
 

The mission of the Harvard Stem Cell Institute is to find cures for human diseases. Through collaborative research in the fields of stem cell and regenerative biology, we seek to:

•  Stimulate healing in patients by harnessing the potential of stem cells

•  Create targeted treatments by combining new gene- and cell-based therapies with  
     traditional medicines

•  Accelerate drug discovery by developing novel stem cell-based tools.

To advance this mission, the Harvard Stem Cell Institute (HSCI) invites applications for collaborative seed grant funding for its 2021 cycle. The purpose of this program is to provide funding for innovative, translationally-focused, collaborative projects with the overarching goal of helping discover new drugs/medicines.

Notably for this application cycle is the requirement that two (or more) investigators from different programs/institutions within the Harvard system collaborate on the project. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.

As part of the application process, applicants will be asked to verify whether their proposal fits the designation of translational science. In determining whether a proposal falls into the translational science category, please consider the aim(s) of your proposal. In general, proposals that fall into the category of translational science are those which aim at:

• Producing new therapies and/or therapeutic products (e.g. cellular products, large/small molecules, biomaterials, etc.), or
• Discovering the mechanisms, pathways, or models underlying such therapies/therapeutic products, or
• Manufacturing and testing stem cell-based therapies using studies designed to fulfill all applicable institutional, state, and federal regulatory requirements

Any seed grants awarded during this cycle will be funded at up to $100,000 in total costs (including indirect costs, maximum 20% of total direct costs-basis) per year, for a period not to exceed two years.

All proposals will be reviewed by the HSCI Executive Committee.

The HSCI reserves the right to not award any seed grants in the 2021 cycle.